Literature DB >> 33914727

Health Care Utilization and Clinical Characteristics of Nonhospitalized Adults in an Integrated Health Care System 28-180 Days After COVID-19 Diagnosis - Georgia, May 2020-March 2021.

Alfonso C Hernandez-Romieu, Serena Leung, Armand Mbanya, Brendan R Jackson, Jennifer R Cope, Dena Bushman, Meredith Dixon, Jessica Brown, Tim McLeod, Sharon Saydah, Deblina Datta, Kate Koplan, Felipe Lobelo.   

Abstract

As of April 19, 2021, 21.6 million COVID-19 cases had been reported among U.S. adults, most of whom had mild or moderate disease that did not require hospitalization (1). Health care needs in the months after COVID-19 diagnosis among nonhospitalized adults have not been well studied. To better understand longer-term health care utilization and clinical characteristics of nonhospitalized adults after COVID-19 diagnosis, CDC and Kaiser Permanente Georgia (KPGA) analyzed electronic health record (EHR) data from health care visits in the 28-180 days after a diagnosis of COVID-19 at an integrated health care system. Among 3,171 nonhospitalized adults who had COVID-19, 69% had one or more outpatient visits during the follow-up period of 28-180-days. Compared with patients without an outpatient visit, a higher percentage of those who did have an outpatient visit were aged ≥50 years, were women, were non-Hispanic Black, and had underlying health conditions. Among adults with outpatient visits, 68% had a visit for a new primary diagnosis, and 38% had a new specialist visit. Active COVID-19 diagnoses* (10%) and symptoms potentially related to COVID-19 (3%-7%) were among the top 20 new visit diagnoses; rates of visits for these diagnoses declined from 2-24 visits per 10,000 person-days 28-59 days after COVID-19 diagnosis to 1-4 visits per 10,000 person-days 120-180 days after diagnosis. The presence of diagnoses of COVID-19 and related symptoms in the 28-180 days following acute illness suggests that some nonhospitalized adults, including those with asymptomatic or mild acute illness, likely have continued health care needs months after diagnosis. Clinicians and health systems should be aware of post-COVID conditions among patients who are not initially hospitalized for acute COVID-19 disease.

Entities:  

Mesh:

Year:  2021        PMID: 33914727     DOI: 10.15585/mmwr.mm7017e3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  12 in total

1.  Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2.

Authors:  Alfonso C Hernandez-Romieu; Thomas W Carton; Sharon Saydah; Eduardo Azziz-Baumgartner; Tegan K Boehmer; Nedra Y Garret; L Charles Bailey; Lindsay G Cowell; Christine Draper; Kenneth H Mayer; Kshema Nagavedu; Jon E Puro; Sonja A Rasmussen; William E Trick; Valentine Wanga; Jennifer R Chevinsky; Brendan R Jackson; Alyson B Goodman; Jennifer R Cope; Adi V Gundlapalli; Jason P Block
Journal:  JAMA Netw Open       Date:  2022-02-01

2.  Differences in access to virtual and in-person primary care by race/ethnicity and community social vulnerability among adults diagnosed with COVID-19 in a large, multi-state health system.

Authors:  Diana J Govier; Hannah Cohen-Cline; Katherine Marsi; Sarah E Roth
Journal:  BMC Health Serv Res       Date:  2022-04-15       Impact factor: 2.908

3.  GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study.

Authors:  Hannah R Whittaker; Claudia Gulea; Ardita Koteci; Constantinos Kallis; Ann D Morgan; Chukwuma Iwundu; Mark Weeks; Rikisha Gupta; Jennifer K Quint
Journal:  BMJ       Date:  2021-12-29

4.  COVID-19 Vaccination Uptake and Hesitancy Among Current Tobacco Users.

Authors:  Nicolle M Krebs; Gail D'Souza; Candace Bordner; Sophia I Allen; Andrea L Hobkirk; Jonathan Foulds; Jessica M Yingst
Journal:  Tob Use Insights       Date:  2021-12-20

5.  PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes.

Authors:  Liqin Wang; Dinah Foer; Erin MacPhaul; Ying-Chih Lo; David W Bates; Li Zhou
Journal:  J Biomed Inform       Date:  2021-11-13       Impact factor: 8.000

6.  Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection.

Authors:  Melissa D Pinto; Natalie Lambert; Charles A Downs; Heather Abrahim; Thomas D Hughes; Amir M Rahmani; Candace W Burton; Rana Chakraborty
Journal:  J Nurse Pract       Date:  2022-02-07       Impact factor: 0.767

7.  Study protocol for the Innovative Support for Patients with SARS-COV-2 Infections Registry (INSPIRE): A longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection.

Authors:  Kelli N O'Laughlin; Matthew Thompson; Bala Hota; Michael Gottlieb; Ian D Plumb; Anna Marie Chang; Lauren E Wisk; Aron J Hall; Ralph C Wang; Erica S Spatz; Kari A Stephens; Ryan M Huebinger; Samuel A McDonald; Arjun Venkatesh; Nikki Gentile; Benjamin H Slovis; Mandy Hill; Sharon Saydah; Ahamed H Idris; Robert Rodriguez; Harlan M Krumholz; Joann G Elmore; Robert A Weinstein; Graham Nichol
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

8.  Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients.

Authors:  Joseph E Herrera; William N Niehaus; Jonathan Whiteson; Alba Azola; John M Baratta; Talya K Fleming; Soo Yeon Kim; Huma Naqvi; Sarah Sampsel; Julie K Silver; Monica Verduzco Gutierrez; Jason Maley; Eric Herman; Benjamin Abramoff
Journal:  PM R       Date:  2021-08-24       Impact factor: 2.298

9.  Differences in Outpatient Health Care Utilization 12 Months after COVID-19 Infection by Race/Ethnicity and Community Social Vulnerability.

Authors:  Sarah E Roth; Diana J Govier; Katherine Marsi; Hannah Cohen-Cline
Journal:  Int J Environ Res Public Health       Date:  2022-03-15       Impact factor: 3.390

10.  Outcomes Among Patients Referred to Outpatient Rehabilitation Clinics After COVID-19 diagnosis - United States, January 2020-March 2021.

Authors:  Jessica S Rogers-Brown; Valentine Wanga; Catherine Okoro; Diane Brozowsky; Alan Evans; David Hopwood; Jennifer R Cope; Brendan R Jackson; Dena Bushman; Alfonso C Hernandez-Romieu; Robert A Bonacci; Tim McLeod; Jennifer R Chevinsky; Alyson B Goodman; Meredith G Dixon; Caitlyn Lutfy; Julie Rushmore; Emily Koumans; Sapna Bamrah Morris; William Thompson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-07-09       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.